McCormack A - Search Results

1

MGMT expression and pituitary tumours: relationship to tumour biology.

McCormack A, Kaplan W, Gill AJ, Little N, Cook R, Robinson B, Clifton-Bligh R. McCormack A, et al. Pituitary. 2013 Jun;16(2):208-19. doi: 10.1007/s11102-012-0406-8. Pituitary. 2013. PMID: 22797801

2

Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours.

McCormack AI, McDonald KL, Gill AJ, Clark SJ, Burt MG, Campbell KA, Braund WJ, Little NS, Cook RJ, Grossman AB, Robinson BG, Clifton-Bligh RJ. McCormack AI, et al. Clin Endocrinol (Oxf). 2009 Aug;71(2):226-33. doi: 10.1111/j.1365-2265.2008.03487.x. Epub 2008 Dec 3. Clin Endocrinol (Oxf). 2009. PMID: 19067722

3

Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases.

Losa M, Mazza E, Terreni MR, McCormack A, Gill AJ, Motta M, Cangi MG, Talarico A, Mortini P, Reni M. Losa M, et al. Among authors: mccormack a. Eur J Endocrinol. 2010 Dec;163(6):843-51. doi: 10.1530/EJE-10-0629. Epub 2010 Sep 24. Eur J Endocrinol. 2010. PMID: 20870708

4

Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status.

McCormack AI, Wass JA, Grossman AB. McCormack AI, et al. Eur J Clin Invest. 2011 Oct;41(10):1133-48. doi: 10.1111/j.1365-2362.2011.02520.x. Epub 2011 Apr 18. Eur J Clin Invest. 2011. PMID: 21496012

5

Germline variants in familial pituitary tumour syndrome genes are common in young patients and families with additional endocrine tumours.

De Sousa SMC, McCabe MJ, Wu K, Roscioli T, Gayevskiy V, Brook K, Rawlings L, Scott HS, Thompson TJ, Earls P, Gill AJ, Cowley MJ, Dinger ME, McCormack AI. De Sousa SMC, et al. Eur J Endocrinol. 2017 May;176(5):635-644. doi: 10.1530/EJE-16-0944. Epub 2017 Feb 20. Eur J Endocrinol. 2017. PMID: 28220018

6

Malignant transformation in non-functioning pituitary adenomas (pituitary carcinoma).

Lenders N, McCormack A. Lenders N, et al. Among authors: mccormack a. Pituitary. 2018 Apr;21(2):217-229. doi: 10.1007/s11102-017-0857-z. Pituitary. 2018. PMID: 29299820 Review.

7

Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016.

McCormack A, Dekkers OM, Petersenn S, Popovic V, Trouillas J, Raverot G, Burman P; ESE survey collaborators. McCormack A, et al. Eur J Endocrinol. 2018 Mar;178(3):265-276. doi: 10.1530/EJE-17-0933. Epub 2018 Jan 12. Eur J Endocrinol. 2018. PMID: 29330228

8

Temozolomide therapy for aggressive pituitary tumours - current understanding and future perspectives.

Burman P, Lamb L, McCormack A. Burman P, et al. Among authors: mccormack a. Rev Endocr Metab Disord. 2020 Jun;21(2):263-276. doi: 10.1007/s11154-020-09551-y. Rev Endocr Metab Disord. 2020. PMID: 32147777 Review.

9

Outcomes of pituitary surgery for Cushing's disease: a systematic review and meta-analysis.

Stroud A, Dhaliwal P, Alvarado R, Winder MJ, Jonker BP, Grayson JW, Hamizan A, Harvey RJ, McCormack A. Stroud A, et al. Among authors: mccormack a. Pituitary. 2020 Oct;23(5):595-609. doi: 10.1007/s11102-020-01066-8. Pituitary. 2020. PMID: 32691356

10

MEN4, the MEN1 Mimicker: A Case Series of three Phenotypically Heterogenous Patients With Unique CDKN1B Mutations.

Seabrook A, Wijewardene A, De Sousa S, Wong T, Sheriff N, Gill AJ, Iyer R, Field M, Luxford C, Clifton-Bligh R, McCormack A, Tucker K. Seabrook A, et al. Among authors: mccormack a. J Clin Endocrinol Metab. 2022 Jul 14;107(8):2339-2349. doi: 10.1210/clinem/dgac162. J Clin Endocrinol Metab. 2022. PMID: 35323929 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

323 results

Search Page

Filters